Roles of activin family in pancreatic development and homeostasis

Molecular and Cellular Endocrinology

Volumn 359, Issue 1-2, 2012, Pages 23-29

  Wiater, Ezra ^a   Vale, Wylie ^a  

^a SALK INSTITUTE FOR BIOLOGICAL STUDIES   (United States)

Author keywords

Activin; Beta cell; Diabetes; Pancreas; Signaling

Indexed keywords

ACTIVIN; ACTIVIN A; BONE MORPHOGENETIC PROTEIN; GDF 11; GROWTH DIFFERENTIATION FACTOR 3; INSULIN; MYELOPID; MYOSTATIN; SMAD2 PROTEIN; SMAD3 PROTEIN; SMAD7 PROTEIN; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG;

BLASTULA; CELL DIFFERENTIATION; CELL MATURATION; CELL PROLIFERATION; CELL TYPE; DEVELOPMENTAL STAGE; EMBRYO DEVELOPMENT; ENERGY METABOLISM; HOMEOSTASIS; HUMAN; INSULIN RELEASE; LIGAND BINDING; METABOLIC REGULATION; NONHUMAN; OBESITY; ORGANOGENESIS; PANCREAS; PANCREAS DEVELOPMENT; PANCREAS FUNCTION; PANCREAS ISLET ALPHA CELL; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; SIGNAL TRANSDUCTION; TISSUE DISTRIBUTION;

ACTIVIN RECEPTORS; ACTIVINS; ANIMALS; BODY PATTERNING; ENERGY METABOLISM; HUMANS; INSULIN; ISLETS OF LANGERHANS; PANCREAS; TGF-BETA SUPERFAMILY PROTEINS;

EID: 84861703053     PISSN: 03037207     EISSN: 18728057     Source Type: Journal    
DOI: 10.1016/j.mce.2012.02.015     Document Type: Review

References (92)

1. Ahnfelt-Ronne J., Ravassard P., Pardanaud-Glavieux C., Scharfmann R., Serup P. Mesenchymal bone morphogenetic protein signaling is required for normal pancreas development. Diabetes 2010, 59:1948-1956.
2. Andersson O., Korach-Andre M., Reissmann E., Ibanez C.F., Bertolino P. Growth/differentiation factor 3 signals through ALK7 and regulates accumulation of adipose tissue and diet-induced obesity. Proc. Natl. Acad. Sci. U. S. A. 2008, 105:7252-7256.
3. Bernardo A.S., Hay C.W., Docherty K. Pancreatic transcription factors and their role in the birth, life and survival of the pancreatic beta cell. Mol. Cell. Endocrinol. 2008, 294:1-9.
4. Bertolino P., Holmberg R., Reissmann E., Andersson O., Berggren P.O., Ibanez C.F. Activin B receptor ALK7 is a negative regulator of pancreatic beta-cell function. Proc. Natl. Acad. Sci. U. S. A. 2008, 105:7246-7251.
5. Brown M.L., Kimura F., Bonomi L.M., Ungerleider N.A., Schneyer A.L. Differential synthesis and action of TGFss superfamily ligands in mouse and rat islets. Islets 2011, 3:367-375.
6. Brun T., Franklin I., St-Onge L., Biason-Lauber A., Schoenle E.J., Wollheim C.B., Gauthier B.R. The diabetes-linked transcription factor PAX4 promotes {beta}-cell proliferation and survival in rat and human islets. J. Cell. Biol. 2004, 167:1123-1135.
7. Brun T., Duhamel D.L., Hu He K.H., Wollheim C.B., Gauthier B.R. The transcription factor PAX4 acts as a survival gene in INS-1E insulinoma cells. Oncogene 2007, 26:4261-4271.
8. Brun T., He K.H., Lupi R., Boehm B., Wojtusciszyn A., Sauter N., Donath M., Marchetti P., Maedler K., Gauthier B.R. The diabetes-linked transcription factor Pax4 is expressed in human pancreatic islets and is activated by mitogens and GLP-1. Hum. Mol. Genet. 2008, 17:478-489.
9. Carlsson L.M., Jacobson P., Walley A., Froguel P., Sjostrom L., Svensson P.A., Sjoholm K. ALK7 expression is specific for adipose tissue, reduced in obesity and correlates to factors implicated in metabolic disease. Biochem. Biophys. Res. Commun. 2009, 382:309-314.
10. Collombat P., Xu X., Ravassard P., Sosa-Pineda B., Dussaud S., Billestrup N., Madsen O.D., Serup P., Heimberg H., Mansouri A. The ectopic expression of Pax4 in the mouse pancreas converts progenitor cells into alpha and subsequently beta cells. Cell 2009, 138:449-462.
11. Conlon F.L., Lyons K.M., Takaesu N., Barth K.S., Kispert A., Herrmann B., Robertson E.J. A primary requirement for nodal in the formation and maintenance of the primitive streak in the mouse. Development 1994, 120:1919-1928.
12. Datto M.B., Frederick J.P., Pan L., Borton A.J., Zhuang Y., Wang X.F. Targeted disruption of Smad3 reveals an essential role in transforming growth factor beta-mediated signal transduction. Mol. Cell. Biol. 1999, 19:2495-2504.
13. Demeterco C., Beattie G.M., Dib S.A., Lopez A.D., Hayek A. A role for activin A and betacellulin in human fetal pancreatic cell differentiation and growth. J. Clin. Endocrinol. Metab. 2000, 85:3892-3897.
14. Derynck R., Miyazono K. TGF-β and TGF-β Family 2008, Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY, pp. 29-43.
15. Dichmann D.S., Miller C.P., Jensen J., Scott Heller R., Serup P. Expression and misexpression of members of the FGF and TGFbeta families of growth factors in the developing mouse pancreas. Dev. Dyn. 2003, 226:663-674.
16. Dichmann D.S., Yassin H., Serup P. Analysis of pancreatic endocrine development in GDF-11-deficient mice. Dev. Dyn. 2006, 235:3016-3025.
17. Ding J., Yang L., Yan Y.T., Chen A., Desai N., Wynshaw-Boris A., Shen M.M. Cripto is required for correct orientation of the anterior-posterior axis in the mouse embryo. Nature 1998, 395:702-707.
18. Finegood D.T., Scaglia L., Bonner-Weir S. Dynamics of beta-cell mass in the growing rat pancreas. Estimation with a simple mathematical model. Diabetes 1995, 44:249-256.
19. Florio P., Luisi S., Marchetti P., Lupi R., Cobellis L., Falaschi C., Sugino H., Navalesi R., Genazzani A.R., Petraglia F. Activin A stimulates insulin secretion in cultured human pancreatic islets. J. Endocrinol. Invest. 2000, 23:231-234.
20. Furukawa M., Eto Y., Kojima I. Expression of immunoreactive activin A in fetal rat pancreas. Endocr. J. 1995, 42:63-68.
21. Goto Y., Nomura M., Tanaka K., Kondo A., Morinaga H., Okabe T., Yanase T., Nawata H., Takayanagi R., Li E. Genetic interactions between activin type IIB receptor and Smad2 genes in asymmetrical patterning of the thoracic organs and the development of pancreas islets. Dev. Dyn. 2007, 236:2865-2874.
22. Goumans M.J., Mummery C. Functional analysis of the TGFbeta receptor/Smad pathway through gene ablation in mice. Int. J. Dev. Biol. 2000, 44:253-265.
23. Gu Z., Nomura M., Simpson B.B., Lei H., Feijen A., van den Eijnden-van Raaij J., Donahoe P.K., Li E. The type I activin receptor ActRIB is required for egg cylinder organization and gastrulation in the mouse. Genes Dev. 1998, 12:844-857.
24. Harmon E.B., Apelqvist A.A., Smart N.G., Gu X., Osborne D.H., Kim S.K. GDF-11 modulates NGN3+ islet progenitor cell number and promotes beta-cell differentiation in pancreas development. Development 2004, 131:6163-6174.
25. Hashimoto O., Ushiro Y., Sekiyama K., Yamaguchi O., Yoshioka K., Mutoh K., Hasegawa Y. Impaired growth of pancreatic exocrine cells in transgenic mice expressing human activin betaE subunit. Biochem. Biophys. Res. Commun. 2006, 341:416-424.
26. Hebrok M., Kim S.K., Melton D.A. Notochord repression of endodermal Sonic hedgehog permits pancreas development. Genes Dev. 1998, 12:1705-1713.
27. Heyer J., Escalante-Alcalde D., Lia M., Boettinger E., Edelmann W., Stewart C.L., Kucherlapati R. Postgastrulation Smad2-deficient embryos show defects in embryo turning and anterior morphogenesis. Proc. Natl. Acad. Sci. U. S. A. 1999, 96:12595-12600.
28. Hill C.S. Nucleocytoplasmic shuttling of Smad proteins. Cell Res. 2009, 19:36-46.
29. Hoggard N., Cruickshank M., Moar K.M., Barrett P., Bashir S., Miller J.D. Inhibin betaB expression in murine adipose tissue and its regulation by leptin, insulin and dexamethasone. J. Mol. Endocrinol. 2009, 43:171-177.
30. Jermendy A., Toschi E., Aye T., Koh A., Aguayo-Mazzucato C., Sharma A., Weir G.C., Sgroi D., Bonner-Weir S. Rat neonatal beta cells lack the specialised metabolic phenotype of mature beta cells. Diabetologia 2011, 54:594-604.
31. Jiang F.X., Stanley E.G., Gonez L.J., Harrison L.C. Bone morphogenetic proteins promote development of fetal pancreas epithelial colonies containing insulin-positive cells. J. Cell Sci. 2002, 115:753-760.
32. Jones R.H., Ozanne S.E. Fetal programming of glucose-insulin metabolism. Mol. Cell. Endocrinol. 2009, 297:4-9.
33. Jornvall H., Reissmann E., Andersson O., Mehrkash M., Ibanez C.F. ALK7, a receptor for nodal, is dispensable for embryogenesis and left-right patterning in the mouse. Mol. Cell. Biol. 2004, 24:9383-9389.
34. Kanno R., Ogihara T., Igarashi Y., Tanaka Y., Smith S.B., Kojima I., German M.S., Kawamori R., Watada H. Activin A-induced expression of PAX4 in AR42J-B13 cells involves the increase in transactivation of E47/E12. Biochim. Biophys. Acta 2006, 1759:44-50.
35. Kim S.K., Hebrok M., Li E., Oh S.P., Schrewe H., Harmon E.B., Lee J.S., Melton D.A. Activin receptor patterning of foregut organogenesis. Genes Dev. 2000, 14:1866-1871.
36. Kogame M., Matsuo S., Nakatani M., Kurisaki A., Nishitani H., Tsuchida K., Sugino H. ALK7 is a novel marker for adipocyte differentiation. J. Med. Invest. 2006, 53:238-245.
37. Kumar M., Jordan N., Melton D., Grapin-Botton A. Signals from lateral plate mesoderm instruct endoderm toward a pancreatic fate. Dev. Biol. 2003, 259:109-122.
38. Li L., Yi Z., Seno M., Kojima I. Activin A and betacellulin: effect on regeneration of pancreatic beta-cells in neonatal streptozotocin-treated rats. Diabetes 2004, 53:608-615.
39. Lin H.M., Lee J.H., Yadav H., Kamaraju A.K., Liu E., Zhigang D., Vieira A., Kim S.J., Collins H., Matschinsky F., Harlan D.M., Roberts A.B., Rane S.G. Transforming growth factor-beta/Smad3 signaling regulates insulin gene transcription and pancreatic islet beta-cell function. J. Biol. Chem. 2009, 284:12246-12257.
40. Lu J., Herrera P.L., Carreira C., Bonnavion R., Seigne C., Calender A., Bertolino P., Zhang C.X. Alpha cell-specific Men1 ablation triggers the transdifferentiation of glucagon-expressing cells and insulinoma development. Gastroenterology 2010, 138:1954-1965.
41. Maldonado T.S., Kadison A.S., Crisera C.A., Grau J.B., Alkasab S.L., Longaker M.T., Gittes G.K. Ontogeny of activin B and follistatin in developing embryonic mouse pancreas: implications for lineage selection. J. Gastrointest. Surg. 2000, 4:269-275.
42. Mamin A., Philippe J. Activin A decreases glucagon and arx gene expression in alpha-cell lines. Mol. Endocrinol. 2007, 21:259-273.
43. Mashima H., Ohnishi H., Wakabayashi K., Mine T., Miyagawa J., Hanafusa T., Seno M., Yamada H., Kojima I. Betacellulin and activin A coordinately convert amylase-secreting pancreatic AR42J cells into insulin-secreting cells. J. Clin. Invest. 1996, 97:1647-1654.
44. Mashima H., Shibata H., Mine T., Kojima I. Formation of insulin-producing cells from pancreatic acinar AR42J cells by hepatocyte growth factor. Endocrinology 1996, 137:3969-3976.
45. Mashima H., Yamada S., Tajima T., Seno M., Yamada H., Takeda J., Kojima I. Genes expressed during the differentiation of pancreatic AR42J cells into insulin-secreting cells. Diabetes 1999, 48:304-309.
46. Massague J. How cells read TGF-beta signals. Nat. Rev. Mol. Cell Biol. 2000, 1:169-178.
47. Matzuk M.M., Kumar T.R., Vassalli A., Bickenbach J.R., Roop D.R., Jaenisch R., Bradley A. Functional analysis of activins during mammalian development. Nature 1995, 374:354-356.
48. Matzuk M.M., Kumar T.R., Bradley A. Different phenotypes for mice deficient in either activins or activin receptor type II. Nature 1995, 374:356-360.
49. Miralles F., Czernichow P., Scharfmann R. Follistatin regulates the relative proportions of endocrine versus exocrine tissue during pancreatic development. Development 1998, 125:1017-1024.
50. Moustakas A., Heldin C.H. The regulation of TGFbeta signal transduction. Development 2009, 136:3699-3714.
51. Mukherjee A., Sidis Y., Mahan A., Raher M.J., Xia Y., Rosen E.D., Bloch K.D., Thomas M.K., Schneyer A.L. FSTL3 deletion reveals roles for TGF-beta family ligands in glucose and fat homeostasis in adults. Proc. Natl. Acad. Sci. U. S. A. 2007, 104:1348-1353.
52. Nomura M., Li E. Smad2 role in mesoderm formation, left-right patterning and craniofacial development. Nature 1998, 393:786-790.
53. Ogihara T., Watada H., Kanno R., Ikeda F., Nomiyama T., Tanaka Y., Nakao A., German M.S., Kojima I., Kawamori R. P38 MAPK is involved in activin A- and hepatocyte growth factor-mediated expression of pro-endocrine gene neurogenin 3 in AR42J-B13 cells. J. Biol. Chem. 2003, 278:21693-21700.
54. Oh S.P., Li E. The signaling pathway mediated by the type IIB activin receptor controls axial patterning and lateral asymmetry in the mouse. Genes Dev. 1997, 11:1812-1826.
55. Palgi J., Stumpf E., Otonkoski T. Transcription factor expression and hormone production in pancreatic AR42J cells. Mol. Cell. Endocrinol. 2000, 165:41-49.
56. Park M.K., Han C., Lee K.H., Hong S.H., Kim H.S., Lee Y.J., Jeong I.K., Noh J.H., Yang T.Y., Lee M.S., Kim K.W., Lee M.K. Effects of activin A on pancreatic ductal cells in streptozotocin-induced diabetic rats. Transplantation 2007, 83:925-930.
57. Schmierer B., Hill C.S. TGFbeta-SMAD signal transduction: molecular specificity and functional flexibility. Nat. Rev. Mol. Cell Biol. 2007, 8:970-982.
58. Schneyer A., Schoen A., Quigg A., Sidis Y. Differential binding and neutralization of activins A and B by follistatin and follistatin like-3 (FSTL-3/FSRP/FLRG). Endocrinology 2003, 144:1671-1674.
59. Schrewe H., Gendron-Maguire M., Harbison M.L., Gridley T. Mice homozygous for a null mutation of activin beta B are viable and fertile. Mech. Dev. 1994, 47:43-51.
60. Shiozaki S., Tajima T., Zhang Y.Q., Furukawa M., Nakazato Y., Kojima I. Impaired differentiation of endocrine and exocrine cells of the pancreas in transgenic mouse expressing the truncated type II activin receptor. Biochim. Biophys. Acta 1999, 1450:1-11.
61. Sidis Y., Mukherjee A., Keutmann H., Delbaere A., Sadatsuki M., Schneyer A. Biological activity of follistatin isoforms and follistatin-like-3 is dependent on differential cell surface binding and specificity for activin, myostatin, and bone morphogenetic proteins. Endocrinology 2006, 147:3586-3597.
62. Sjoholm K., Palming J., Lystig T.C., Jennische E., Woodruff T.K., Carlsson B., Carlsson L.M. The expression of inhibin beta B is high in human adipocytes, reduced by weight loss, and correlates to factors implicated in metabolic disease. Biochem. Biophys. Res. Commun. 2006, 344:1308-1314.
63. Slack J.M. Developmental biology of the pancreas. Development 1995, 121:1569-1580.
64. Smart N.G., Apelqvist A.A., Gu X., Harmon E.B., Topper J.N., MacDonald R.J., Kim S.K. Conditional expression of Smad7 in pancreatic beta cells disrupts TGF-beta signaling and induces reversible diabetes mellitus. PLoS Biol. 2006, 4:e39.
65. Song J., Oh S.P., Schrewe H., Nomura M., Lei H., Okano M., Gridley T., Li E. The type II activin receptors are essential for egg cylinder growth, gastrulation, and rostral head development in mice. Dev. Biol. 1999, 213:157-169.
66. Szabat M., Johnson J.D., Piret J.M. Reciprocal modulation of adult beta cell maturity by activin A and follistatin. Diabetologia 2010, 53:1680-1689.
67. Tan C.K., Leuenberger N., Tan M.J., Yan Y.W., Chen Y., Kambadur R., Wahli W., Tan N.S. Smad3 deficiency in mice protects against insulin resistance and obesity induced by a high-fat diet. Diabetes 2011, 60:464-476.
68. ten Dijke P., Hill C.S. New insights into TGF-beta-Smad signalling. Trends Biochem. Sci. 2004, 29:265-273.
69. Teta M., Long S.Y., Wartschow L.M., Rankin M.M., Kushner J.A. Very slow turnover of beta-cells in aged adult mice. Diabetes 2005, 54:2557-2567.
70. Thorel F., Nepote V., Avril I., Kohno K., Desgraz R., Chera S., Herrera P.L. Conversion of adult pancreatic alpha-cells to beta-cells after extreme beta-cell loss. Nature 2010, 464:1149-1154.
71. Tortoriello D.V., Sidis Y., Holtzman D.A., Holmes W.E., Schneyer A.L. Human follistatin-related protein: a structural homologue of follistatin with nuclear localization. Endocrinology 2001, 142:3426-3434.
72. Tsuchida K., Nakatani M., Yamakawa N., Hashimoto O., Hasegawa Y., Sugino H. Activin isoforms signal through type I receptor serine/threonine kinase ALK7. Mol. Cell. Endocrinol. 2004, 220:59-65.
73. Ueda Y. Activin A increases Pax4 gene expression in pancreatic beta cell lines. FEBS Lett. 2000, 480:101-105.
74. van Eyll J.M., Pierreux C.E., Lemaigre F.P., Rousseau G.G. Shh-dependent differentiation of intestinal tissue from embryonic pancreas by activin A. J. Cell Sci. 2004, 117:2077-2086.
75. Vassalli A., Matzuk M.M., Gardner H.A., Lee K.F., Jaenisch R. Activin/inhibin beta B subunit gene disruption leads to defects in eyelid development and female reproduction. Genes Dev. 1994, 8:414-427.
76. Verschueren K., Dewulf N., Goumans M.J., Lonnoy O., Feijen A., Grimsby S., Vandi Spiegle K., ten Dijke P., Moren A., Vanscheeuwijck P., Heldin C.H., Miyazono K., Mummery C., Van Den Eijnden-Van Raaij J., Huylebroeck D. Expression of type I and type IB receptors for activin in midgestation mouse embryos suggests distinct functions in organogenesis. Mech. Dev. 1995, 52:109-123.
77. Waldrip W.R., Bikoff E.K., Hoodless P.A., Wrana J.L., Robertson E.J. Smad2 signaling in extraembryonic tissues determines anterior-posterior polarity of the early mouse embryo. Cell 1998, 92:797-808.
78. Watanabe R., Yamada Y., Ihara Y., Someya Y., Kubota A., Kagimoto S., Kuroe A., Iwakura T., Shen Z.P., Inada A., Adachi T., Ban N., Miyawaki K., Sunaga Y., Tsuda K., Seino Y. The MH1 domains of smad2 and smad3 are involved in the regulation of the ALK7 signals. Biochem. Biophys. Res. Commun. 1999, 254:707-712.
79. Watanabe R., Shen Z.P., Tsuda K., Yamada Y. Insulin gene is a target in activin receptor-like kinase 7 signaling pathway in pancreatic beta-cells. Biochem. Biophys. Res. Commun. 2008, 377:867-872.
80. Weinstein M., Yang X., Li C., Xu X., Gotay J., Deng C.X. Failure of egg cylinder elongation and mesoderm induction in mouse embryos lacking the tumor suppressor smad2. Proc. Natl. Acad. Sci. U. S. A. 1998, 95:9378-9383.
81. Wilson M.E., Scheel D., German M.S. Gene expression cascades in pancreatic development. Mech. Dev. 2003, 120:65-80.
82. Yadav H., Quijano C., Kamaraju A.K., Gavrilova O., Malek R., Chen W., Zerfas P., Zhigang D., Wright E.C., Stuelten C., Sun P., Lonning S., Skarulis M., Sumner A.E., Finkel T., Rane S.G. Protection from obesity and diabetes by blockade of TGF-beta/Smad3 signaling. Cell Metab 2011, 14:67-79.
83. Yamaoka T., Idehara C., Yano M., Matsushita T., Yamada T., Ii S., Moritani M., Hata J., Sugino H., Noji S., Itakura M. Hypoplasia of pancreatic islets in transgenic mice expressing activin receptor mutants. J. Clin. Invest. 1998, 102:294-301.
84. Yang X., Letterio J.J., Lechleider R.J., Chen L., Hayman R., Gu H., Roberts A.B., Deng C. Targeted disruption of SMAD3 results in impaired mucosal immunity and diminished T cell responsiveness to TGF-beta. EMBO J. 1999, 18:1280-1291.
85. Yasuda H., Tanaka S., Ohnishi H., Mashima H., Ogushi N., Mine T., Kojima I. Activin A: negative regulator of amylase secretion and cell proliferation in rat pancreatic acinar AR42J cells. Am. J. Physiol. 1994, 267:G220-G226.
86. Yasuda M., Yamamoto M., Ochiai H., Eguchi Y., Arishima K. Effects of growth factors on development of fetal islet B-cells in vitro. J. Vet. Med. Sci. 2007, 69:807-811.
87. Zaret K.S., Grompe M. Generation and regeneration of cells of the liver and pancreas. Science 2008, 322:1490-1494.
88. Zhang Y.Q., Mashima H., Kojima I. Changes in the expression of transcription factors in pancreatic AR42J cells during differentiation into insulin-producing cells. Diabetes 2001, 50(Suppl 1):S10-S14.
89. Zhang Y.Q., Cleary M.M., Si Y., Liu G., Eto Y., Kritzik M., Dabernat S., Kayali A.G., Sarvetnick N. Inhibition of activin signaling induces pancreatic epithelial cell expansion and diminishes terminal differentiation of pancreatic beta-cells. Diabetes 2004, 53:2024-2033.
90. Zhang N., Kumar M., Xu G., Ju W., Yoon T., Xu E., Huang X., Gaisano H., Peng C., Wang Q. Activin receptor-like kinase 7 induces apoptosis of pancreatic beta cells and beta cell lines. Diabetologia 2006, 49:506-518.
91. Zhang Y.Q., Sterling L., Stotland A., Hua H., Kritzik M., Sarvetnick N. Nodal and lefty signaling regulates the growth of pancreatic cells. Dev. Dyn. 2008, 237:1255-1267.
92. Zhou X., Sasaki H., Lowe L., Hogan B.L., Kuehn M.R. Nodal is a novel TGF-beta-like gene expressed in the mouse node during gastrulation. Nature 1993, 361:543-547.